OncoMed’s Cancer Stem Cell Therapies Could Provide Outsized Gains For … – Seeking Alpha
|
OncoMed’s Cancer Stem Cell Therapies Could Provide Outsized Gains For …
Seeking Alpha In August 2009, Cell Stem Cell published results from preclinical experiments conducted to examine the effects of anti-DLL4 in xenograft models derived from primary human tumors (primarily colon tumors). Anti-DLL4 was evaluated alone and in combination … |
